Shares of Pacific Biosciences of California slid 6.75% to $25.43 at 14:39 EST on Tuesday, after five consecutive sessions in a row of losses. NASDAQ Composite is sliding 2.48% to $13,550.11, after two sequential sessions in a row of losses. This seems, up to now, an all-around rough trend trading session today.

Pacific Biosciences of California’s last close was $27.27, 111.13% below its 52-week high of $53.69.

Pacific Biosciences of California’s Sales

Pacific Biosciences of California’s sales growth is 74.4% for the present quarter and 71.5% for the next. The company’s growth estimates for the current quarter and the next is a negative 40% and a negative 57.1%, respectively.

Pacific Biosciences of California’s Revenue

Year-on-year quarterly revenue growth grew by 85.9%, now sitting on 92.29M for the twelve trailing months.

Pacific Biosciences of California’s Stock Yearly Top and Bottom Value

Pacific Biosciences of California’s stock is valued at $25.43 at 14:39 EST, way below its 52-week high of $53.69 and way higher than its 52-week low of $2.66.

Pacific Biosciences of California’s Moving Average

Pacific Biosciences of California’s worth is way below its 50-day moving average of $33.94 and above its 200-day moving average of $24.72.

More news about Pacific Biosciences of California.

LEAVE A REPLY

Please enter your comment!
Please enter your name here